stars 1 stars 2 stars 3

Aptarion is dedicated to leveraging the strengths of biostable L-aptamers (highly specific "chemical antibodies") across the biomedical spectrum. Besides the discovery of new L-aptamers for the functionalization of sensors with its powerful platform technology, Aptarion pursues the development of its proprietary existing L-aptamers as therapeutics in areas of high medical need.

Aptarion biotech AG Questions

The Aptarion biotech AG annual revenue was $3 million in 2026.

Sven Klussmann is the Founder and Chief Executive Officer (CEO) of Aptarion biotech AG.

5 people are employed at Aptarion biotech AG.

Aptarion biotech AG is based in Berlin, Berlin.

The NAICS codes for Aptarion biotech AG are [541, 54, 541713, 5417, 54171].

The SIC codes for Aptarion biotech AG are [87, 873].

Top Aptarion biotech AG Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users